Pernix Therapeutics Agrees to Buy Beleaguered Somaxon Pharmaceuticals
By Heather Cartwright
Pharma Deals Review: Vol 2013 Issue 1 (Table of Contents)
Published: 2 Jan-2013
DOI: 10.3833/pdr.v2013.i1.1867 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In order to expand its product portfolio further beyond paediatric drugs, Pernix Therapeutics has agreed to acquire Somaxon Pharmaceuticals in a US$25 M stock-for-stock deal...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS